HLTH

Nobilis Health Corp.

HLTH

Delisted

HLTH was delisted on the 3rd of September, 2019.

Back to rankings

Healthcare Medical Care Facilities

Financial journalist opinion

Why Is Cue Health (HLTH) Stock Up 99% Today?

Cue Health (NASDAQ: HLTH ) stock is up on Thursday despite the healthcare technology company recently announcing plans to wind down its business. Cue Health revealed earlier this week that it's closing up shop with its Chapter 7 bankruptcy relief filing.

Why Is Cue Health (HLTH) Stock Down 40% Today?

Cue Health (NASDAQ: HLTH ) stock is down on Wednesday after the healthcare technology company announced plans to wind down its business. According to a press release from Cue Health, the company has filed voluntary petitions under Chapter 7 of the U.S. Bankruptcy Code to pursue this wind-down.

Cue Health to Pursue Wind Down of the Business

SAN DIEGO--(BUSINESS WIRE)--Cue Health Inc. ("Cue" or the “Company”) (Nasdaq: HLTH), a healthcare technology company, today announced the Company has filed voluntary petitions under Chapter 7 of the U.S. Bankruptcy Code in the District of Delaware to pursue a wind down of its business. Cue has been working diligently to strengthen the Company's financial foundation, including taking a number of actions to reduce costs and improve operational efficiency. Cue also undertook an extensive process t.

Cue Health to Pursue Wind Down of the Business

Cue Health Evaluating Warning Letter Received from Food and Drug Administration (FDA)

SAN DIEGO--(BUSINESS WIRE)--Cue Health Inc. (Nasdaq: HLTH), a healthcare technology company (the “Company”), has received a warning letter from the FDA about its Emergency Use Authorized (EUA) COVID-19 test. The Company is currently evaluating the letter and determining its response, with more information to follow in the next few days. About Cue Cue Health Inc. (Nasdaq: HLTH) is a healthcare technology company that empowers healthcare providers to streamline their ability to deliver value-base.

Cue Health Evaluating Warning Letter Received from Food and Drug Administration (FDA)

Cue Health to Announce First Quarter Financial Results

SAN DIEGO--(BUSINESS WIRE)--Cue Health Inc. (“Cue”) (Nasdaq: HLTH), a healthcare technology company, announced today that it will release its first quarter 2024 financial results on Monday, May 13, 2024. The company will not be hosting a conference call. About Cue Health Cue Health Inc. (Nasdaq: HLTH) is a healthcare technology company that uses diagnostic-enabled care to empower people to live their healthiest lives. Cue's platform offers individuals and healthcare providers convenient and per.

Cue Health to Announce First Quarter Financial Results

Cue Health Announces Strategic Actions to Position Company for Next Stage

SAN DIEGO--(BUSINESS WIRE)--Cue Health Inc. ("Cue" or the “Company”) (Nasdaq: HLTH), a healthcare technology company, today announced strategic actions implemented by its Board of Directors (the “Board”) to best position the Company for its next stage: Clint Sever, co-founder and current Chief Product Officer, has been appointed CEO, effective immediately. Sever succeeds Ayub Khattak, who is stepping down as Chief Executive Officer, President, and Chairman. Khattak will remain a member of the B.

Cue Health Announces Strategic Actions to Position Company for Next Stage

3 Promising Penny Stocks You Can Pick Up for Less Than a Quarter

Listen, if you haven't gotten the memo, penny stocks are incredibly dangerous. Yes, they're cheap – in this case, extremely cheap.

Cue Health, Inc. (HLTH) Q4 2023 Earnings Call Transcript

Cue Health, Inc. (HLTH) Q4 2023 Earnings Call Transcript

Zacks Investment Research

Cue Health Inc. (HLTH) Reports Q4 Loss, Tops Revenue Estimates

Cue Health Inc. (HLTH) came out with a quarterly loss of $0.32 per share versus the Zacks Consensus Estimate of a loss of $0.45. This compares to loss of $0.50 per share a year ago.

Cue Health Reports Fourth Quarter 2023 Financial Results

SAN DIEGO--(BUSINESS WIRE)--Cue Health Inc. ("Cue" or the “Company”) (Nasdaq: HLTH), a healthcare technology company, today reported financial results for the fourth quarter and full-year 2023. Recent Highlights Reported fourth quarter total revenue of $18.8 million. Full-year 2023 total revenue was $70.9 million Submitted additional clinical samples and stability data for RSV to the FDA in support of de novo submission Submitted additional clinical samples and gathering additional stability da.

Cue Health Reports Fourth Quarter 2023 Financial Results

See News Rankings

Charts implemented using Lightweight Charts™